The Flex Company

flexfits.com →

-86%

est. 2Y upside i

Series A

Sustainable period care.

Rank

#3862

Sector

FemTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

The Flex Company operates in a growing FemTech market with innovative, patented products and a hybrid revenue model, but faces significant challenges.

Last updated: February 25, 2026

Bull (10%)+400%

The Flex Company successfully leverages its patented products and the Allbodies acquisition to expand into new customer segments and product lines, achieving significant retail penetration and DTC growth. This drives revenue to over $50M by 2028, justifying a $450M valuation at exit, well above the current estimated $90M.

Base (35%)+20%

The company maintains its niche market position, growing steadily through online sales and limited retail expansion, but faces ongoing competitive pressure from incumbents. Revenue grows to ~$20M by 2028, leading to an acquisition or modest funding round at a $108M valuation, offering limited upside from the current estimated $90M.

Bear (55%)-80%

Dominant incumbents like Procter & Gamble and Kimberly-Clark aggressively enter the sustainable period product market with competitive offerings and superior distribution, commoditizing Flex's products. This leads to stalled growth and a down round or distressed acquisition at an $18M valuation, wiping out most common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $19M in liquidation preferences. In an estimated $90M exit, common shareholders would receive $71M. In an $18M bear case exit, common shareholders would receive nothing.

Dilution Risk

high

Given the company's stage and total funding, more funding rounds are highly likely, which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

As a private, venture-backed company at this stage, there is currently no active secondary market or tender offers for employee equity.

Questions to Ask at the Interview

Strategic questions based on The Flex Company's data — designed to show you've done your homework.

  • 1

    “Given the strong market presence of incumbents like Procter & Gamble and Kimberly-Clark in the feminine hygiene space, how does The Flex Company plan to expand its market share and defend its patented products against their extensive resources and distribution?”

  • 2

    “With $14M in revenue and the last stated funding round being Series A in 2018, what is the company's current growth trajectory, and what are the key milestones for achieving profitability or the next funding round?”

  • 3

    “Considering the $19M in total funding and the current stage, what is the anticipated timeline for a liquidity event for employees, and how does the company plan to manage potential dilution in future funding rounds?”

Community

Valuation Sentiment

Our model estimates -86% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.